Carlo Lucchesi

6.9k total citations · 1 hit paper
44 papers, 3.1k citations indexed

About

Carlo Lucchesi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Carlo Lucchesi has authored 44 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Carlo Lucchesi's work include Sarcoma Diagnosis and Treatment (18 papers), Cancer Genomics and Diagnostics (10 papers) and Chromatin Remodeling and Cancer (6 papers). Carlo Lucchesi is often cited by papers focused on Sarcoma Diagnosis and Treatment (18 papers), Cancer Genomics and Diagnostics (10 papers) and Chromatin Remodeling and Cancer (6 papers). Carlo Lucchesi collaborates with scholars based in France, Italy and Switzerland. Carlo Lucchesi's co-authors include Olivier Delattre, Jean‐Michel Coindre, Gaëlle Pierron, Franck Tirode, Anne Vincent‐Salomon, Antoîne Italiano, Xavier Sastre‐Garau, Stelly Ballet, Stéphanie Reynaud and Virginie Perrin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Carlo Lucchesi

44 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study

2018 451 citations Antoîne Italiano, Maud Toulmonde et al. profile →

Peers

Countries citing papers authored by Carlo Lucchesi

Since Specialization

Citations

This map shows the geographic impact of Carlo Lucchesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Lucchesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Lucchesi more than expected).

Fields of papers citing papers by Carlo Lucchesi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Lucchesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Lucchesi. The network helps show where Carlo Lucchesi may publish in the future.

Co-authorship network of co-authors of Carlo Lucchesi

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Lucchesi. A scholar is included among the top collaborators of Carlo Lucchesi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Lucchesi. Carlo Lucchesi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosis 2024 ·npj Precision Oncology ·Amandine Crombé, Carlo Lucchesi, (unknown), Michèle Kind, Mariella Spalato Ceruso, Maud Toulmonde, Vanessa Chaire, Audrey Michot, Jean‐Michel Coindre, Raul Perret, François Le Loarer, (unknown), Antoîne Italiano	4
2	Distinct patterns of the natural evolution of soft tissue sarcomas on pre-treatment MRIs captured with delta-radiomics correlate with gene expression profiles 2022 ·European Radiology ·Amandine Crombé, (unknown), (unknown), Michèle Kind, François Le Loarer, Raul Perret, Vanessa Chaire, Paolo Spinnato, Carlo Lucchesi, Antoîne Italiano	11
3	High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies 2020 ·EBioMedicine ·Maud Toulmonde, Carlo Lucchesi, Stéphanie Verbeke, Amandine Crombé, Julien Adam, (unknown), Vanessa Chaire, Audrey Laroche‐Clary, Raul Perret, François Bertucci, (unknown), Laurence Bianchini, Bérengère Dadone‐Montaudié, Todd Hembrough, Stephen T. Sweet, Yeoun Jin Kim, Franco Cecchi, François Le Loarer, Antoîne Italiano	40
4	Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study 2019 ·Clinical Cancer Research ·Maud Toulmonde, Jean‐Yves Blay, Olivier Bouché, Olivier Mir, Nicolas Penel, Nicolás Isambert, Florence Duffaud, Emmanuelle Bompas, (unknown), Romain Boidot, (unknown), François Ghiringhelli, Carlo Lucchesi, Carine Bellera, François Le Loarer, Antoîne Italiano	14
5	Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition 2019 ·Journal of Hematology & Oncology ·(unknown), (unknown), Bérengère Dadone, Carlo Lucchesi, Scott R. Daigle, Élodie Richard, Audrey Laroche‐Clary, François Le Loarer, Antoîne Italiano	15
6	CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications 2018 ·Annals of Oncology ·Audrey Laroche‐Clary, Carlo Lucchesi, Christophe Rey, Stéphanie Verbeke, (unknown), Vanessa Chaire, (unknown), Sophie Cousin, Maud Toulmonde, Valérie Velasco, (unknown), Ariel Savina, François Le Loarer, Antoîne Italiano	14
7	Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas 2017 ·Journal of Hematology & Oncology ·(unknown), Vanessa Chaire, François Le Loarer, (unknown), Christophe Rey, (unknown), Carlo Lucchesi, Antoîne Italiano	23
8	High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine 2017 ·European Journal of Cancer ·Thomas Grellety, Carlo Lucchesi, Isabelle Hostein, Céline Auzanneau, Emmanuel Khalifa, Isabelle Soubeyran, Antoîne Italiano	6
9	Molecular profiling of patient-derived breast cancer xenografts 2012 ·Breast Cancer Research ·Fabien Reyal, Charlotte Guyader, Charles Decraene, Carlo Lucchesi, Nathalie Auger, Franck Assayag, Ludmilla de Plater, David Gentien, Marie‐France Poupon, Paul Cottu, Patricia de Crémoux, Pierre Gestraud, Anne Vincent‐Salomon, Jean‐Jacques Fontaine, Sergio Roman‐Roman, Olivier Delattre, Didier Decaudin, Elisabetta Marangoni	140
10	A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion 2012 ·Nature Genetics ·Gaëlle Pierron, Franck Tirode, Carlo Lucchesi, Stéphanie Reynaud, Stelly Ballet, Sarah Cohen‐Gogo, Virginie Perrin, Jean‐Michel Coindre, Olivier Delattre	328
11	Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma 2010 ·European Journal of Cancer ·Nadège Gruel, Carlo Lucchesi, Virginie Raynal, Manuel Rodrigues, Gaëlle Pierron, (unknown), Paul Cottu, Fabien Reyal, Xavier Sastre‐Garau, Alain Fourquet, Olivier Delattre, Anne Vincent‐Salomon	50
12	Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity 2010 ·Nature Medicine ·Frédéric Chibon, Pauline Lagarde, Sébastien Salas, Gaëlle Pérot, Véronique Brouste, Franck Tirode, Carlo Lucchesi, Aurélien de Reyniès, Audrey Kauffmann, Binh Bui, Philippe Terrier, Sylvie Bonvalot, Axel Le Cesne, Dominique Vince-Ranchère, Jean‐Yves Blay, Françoise Collin, Louis Guillou, Agnès Leroux, Jean‐Michel Coindre, Alain Aurias	303
13	Strong Smooth Muscle Differentiation Is Dependent on Myocardin Gene Amplification in Most Human Retroperitoneal Leiomyosarcomas 2009 ·Cancer Research ·Gaëlle Pérot, Josette Derré, Jean‐Michel Coindre, Franck Tirode, Carlo Lucchesi, Odette Mariani, Laure Gibault, Louis Guillou, Philippe Terrier, Alain Aurias	50
14	Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast 2008 ·Clinical Cancer Research ·Anne Vincent‐Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, (unknown), Fabien Reyal, François Radvanyi, Rémy Salmon, Jean Paul Thiery, Xavier Sastre‐Garau, Brigitte Sigal‐Zafrani, Alain Fourquet, Olivier Delattre, (unknown)	114
15	Characterization of amplicons in neuroblastoma: High‐resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes 2008 ·Genes Chromosomes and Cancer ·(unknown), Carlo Lucchesi, Agnès Ribeiro, Delphine Lequin, Gaëlle Pierron, Gudrun Schleiermacher, Olivier Delattre, Isabelle Janoueix‐Lerosey	37
16	Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity 2007 ·Breast Cancer Research ·Anne Vincent‐Salomon, Nadège Gruel, Carlo Lucchesi, Gaëtan MacGrogan, R. Dendale, Brigitte Sigal‐Zafrani, Michel Longy, Virginie Raynal, Gaëlle Pierron, Isabelle de Mascarel, (unknown), Dominique Stoppa‐Lyonnet, Jean‐Yves Pierga, Rémy Salmon, Xavier Sastre‐Garau, Alain Fourquet, Olivier Delattre, Patricia de Crémoux, Alain Aurias	133
17	BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas 2007 ·International Journal of Cancer ·Ahmed Idbaïh, Yannick Marie, Carlo Lucchesi, Gaëlle Pierron, Élodie Manié, Virginie Raynal, Véronique Mosseri, Khê Hoang‐Xuan, M. Kujas, Isabel Martínez Brito, Karima Mokhtari, Marc Sanson, Emmanuel Barillot, Alain Aurias, Jean‐Yves Delattre, Olivier Delattre	88
18	Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome 2006 ·Proceedings of the National Academy of Sciences ·Jacques‐Eric Gottenberg, Nicolas Cagnard, Carlo Lucchesi, Franck Letourneur, Sylvie Mistou, Thierry Lazure, Sébastien Jacques, Nathalie Bâ, Marc Ittah, Christine Lepajolec, Marc Labétoulle, M. Ardizzone, Jean Sibilia, Catherine Fournier, Gilles Chiocchia, Xavier Mariette	446
19	Novel Microarray-Based Method for Estimating Exposure to Ionizing Radiation 2006 ·Radiation Research ·Gaëtan Gruel, Carlo Lucchesi, Alexandre Pawlik, Vincent Frouin, Olivier Alibert, Thierry Kortulewski, (unknown), Béatrice Jacquelin, Xavier Gidrol, (unknown)	20
20	DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets 2004 ·Genes and Immunity ·Valérie Devauchelle, (unknown), Nicolas Cagnard, Sylvie Mistou, Géraldine Falgarone, Maxime Bréban, Franck Letourneur, Amandine Pitaval, Olivier Alibert, Carlo Lucchesi, Philippe Anract, Moussa Hamadouche, X Ayral, Maxime Dougados, Xavier Gidrol, Catherine Fournier, Gilles Chiocchia	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact